(0.07%) 5 051.00 points
(0.05%) 38 486 points
(0.13%) 17 373 points
(-1.07%) $81.96
(0.73%) $1.804
(-1.59%) $2 309.10
(-1.89%) $26.73
(-1.21%) $920.00
(-0.06%) $0.938
(0.18%) $11.01
(-0.10%) $0.809
(-0.12%) $93.30
Live Chart Being Loaded With Signals
Broncus Holding Corporation, a medical device company, focuses on the development of interventional pulmonology products in Mainland China, the European Union, the United States, and internationally...
Stats | |
---|---|
Today's Volume | 222 000 |
Average Volume | 203 230 |
Market Cap | 274.14M |
EPS | HKD0 ( 2024-03-27 ) |
Last Dividend | HKD0 ( N/A ) |
Next Dividend | HKD0 ( N/A ) |
P/E | -1.110 |
ATR14 | HKD0 (0.00%) |
Broncus Holding Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Broncus Holding Financials
Annual | 2022 |
Revenue: | HKD9.41M |
Gross Profit: | HKD7.32M (77.71 %) |
EPS: | HKD-0.0575 |
Q2 | 2023 |
Revenue: | HKD2.62M |
Gross Profit: | HKD2.01M (76.92 %) |
EPS: | HKD-0.0151 |
Q1 | 2023 |
Revenue: | HKD2.62M |
Gross Profit: | HKD2.01M (76.92 %) |
EPS: | HKD-0.0151 |
Q4 | 2022 |
Revenue: | HKD3.10M |
Gross Profit: | HKD2.43M (78.34 %) |
EPS: | HKD-0.0123 |
Financial Reports:
No articles found.
Broncus Holding
Broncus Holding Corporation, a medical device company, focuses on the development of interventional pulmonology products in Mainland China, the European Union, the United States, and internationally. The company provides navigation products, such as LungPoint Virtual Bronchoscopic Navigation, a computer-assisted image-based navigation software system; LungPoint Plus, a system that provides real-time navigation within the airways for lung biopsy and other procedures; and LungPro, a virtual bronchoscopic navigation product that provides three-dimensional real-time guided transbronchial needle aspiration and proprietary parenchymal navigation. It also offers treatment products comprising InterVapor, a targeted bronchoscopic thermal vapor ablation to ablate the diseased hyper-inflated lung segments; RF Generator + RF Ablation Catheter, a radiofrequency ablation system used in conjunction with a disposable lung radiofrequency ablation catheter, as well as radiofrequency ablation system that targets lung cancer; and H-Marker, a pulmonary surgical marker. In addition, the company provides treatment products, such as BioStarNeedle, a single use ultrasound-guided aspiration needle for retrieval of tissue samples; FleXNeedle, a multipurpose biopsy needle; Archimedes Sheath, a sterile single-use flexible tube that provides a working channel during a bronchoscopic procedure; Archimedes Dilation Balloon, a sterile single-use flexible tube with a balloon at or near the distal tip that is inserted through the bronchoscope or sheath and used to dilate the target lung tissue of the bronchial tree; and Steerable Sheath, a steerable sheath adjustment handle and a working channel. Broncus Holding Corporation was incorporated in 2012 and is headquartered in Hangzhou, China.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators